Analysis of data from the GSCA database revealed a significant positive correlation between BAP31 expression and CNV in patients with head and neck cancer (HNSC), liver cancer (LIHC), sarcoma (SARC), and gastric cancer (STAD). Here, BCAP31 is linked to liver cancer.